NCT06907290Phase 2, phase 3Active not recruiting

A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection

Study sponsor: Mirum Pharmaceuticals, Inc. · MIRM

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2029-05Estimated

Enrollment · participants150Estimated

Source updated2026-03-02Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-02-25 · 2 fields changed

Primary completion date changed

− Before

~~Jun 2027~~

+ After

May 2029

Recruitment status changed

− Before

~~Recruiting~~

+ After

Active not recruiting

Check registry source